Evidence map›Paper›PMID 38856956›Full record

ArticleJournal of cellular and molecular medicine2024

Overexpression of olfactory receptor 78 ameliorates brain injury in cerebral ischaemia-reperfusion rats by activating Prkaca-mediated cAMP/PKA-MAPK pathway.

Tao Kang, Lijuan Zhu, Yanli Xue, Qian Yang, Qi Lei, Qianqian Wang

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Olfactory receptors and human diseases.Cell and tissue research · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tao KangDepartment of Neurology, Shaanxi Provincial People's Hospital, Xi'an, China.
Lijuan ZhuDepartment of Anesthesia, Shaanxi Provincial People's Hospital, Xi'an, China.
Yanli XueDepartment of Neurology, Shaanxi Provincial People's Hospital, Xi'an, China.
Qian YangDepartment of Neurology, Shaanxi Provincial People's Hospital, Xi'an, China.
Qi LeiDepartment of Neurology, Shaanxi Provincial People's Hospital, Xi'an, China.ORCID 0009-0008-2525-6746
Qianqian WangDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Funding

the Funding project of basic research of natural sciences in Shaanxi Province 2022JM-590
6 · The paper itself

Abstract

Ischemic stroke is one of the main causes of disability and death. However, recanalization of occluded cerebral arteries is effective only within a very narrow time window. Therefore, it is particularly important to find neuroprotective biological targets for cerebral artery recanalization. Here, gene expression profiles of datasets GSE160500 and GSE97537 were downloaded from the GEO database, which were related to ischemic stroke in rats. Olfactory receptor 78 (Olfr78) was screened, and which highly associated with Calcium signalling pathway and MAPK pathway. Interacting protein of Olfr78, Prkaca, was predicted by STRING, and their interaction was validated by Co-IP analysis. Then, a rat model of middle cerebral artery occlusion/reperfusion (MCAO/R) and a neuronal cell model stimulated by oxygen-glucose deprivation/reoxygenation (OGD/R) were constructed, and the results showed that expression of Olfr78 and Prkaca was downregulated in MCAO rats and OGD/R-stimulated neurons. Overexpression of Olfr78 or Prkaca inhibited the secretion of inflammatory factors, Ca

Indexed as

Cyclic AMPReceptors, OdorantReperfusion InjurySignal TransductionAnimalsApoptosisBrain InjuriesBrain IschemiaCyclic AMP-Dependent Protein KinasesDisease Models, AnimalInfarction, Middle Cerebral ArteryMaleMAP Kinase Signaling SystemNeuronsRatsRats, Sprague-DawleyCyclic AMPCyclic AMP-Dependent Protein KinasesReceptors, OdorantCa2+ depositionischemic strokeOlfr78Prkacathe cAMP/PKA‐MAPK signalling pathway

Identifiers

PMID38856956
PMCPMC11163950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.